Research peptide
PT-141
PT-141 (Bremelanotide) is a cyclic heptapeptide and metabolite of Melanotan II that acts as a non-selective melanocortin receptor agonist, with notable affinity for the MC3R and MC4R subtypes. Unlike peripherally acting vasoactive compounds, it works centrally through the nervous system, which makes it a distinctive tool for neuroendocrine and central-arousal pathway research. Lyophilised powder, 10mg vial, ≥99% purity by HPLC, Certificate of Analysis on request. UK-based dispatch for laboratory research only. Research applications Melanocortin receptor (MC1R-MC5R) agonism and binding studies Central-nervous-system arousal signalling research models Neuroendocrine and hypothalamic pathway investigation Peptide-mediated mood and behaviour modulation research Comparative receptor engagement against Melanotan II Specifications Form: Lyophilised powder Purity: ≥99% (HPLC verified) Storage: −20°C, protected from light and moisture Available sizes: 10mg Certificate of Analysis: available on request
Size: 10mg
Multi-buy discount available
- Buy 2Save 5%
- Buy 3Save 10%
- Buy 5Save 15%
- Buy 10Save 20%
- 99%+ purity guaranteed
- COA available
- Same-day dispatch
- Secure checkout
Product details
- PT-141 receptor binding and agonism assays in controlled laboratory settings.
- In vitro pathway signalling studies requiring batch-documented research material.
- Analytical method development and HPLC reference characterisation.
- Institutional protocol workstreams that require published Certificates of Analysis.
